Cell & Gene Therapy Review

Home
United States
San Francisco, CA
Cell & Gene Therapy Review

The Industry’s Newest Authority on Cell and Gene Therapy Business and Technology.

02/27/2025

𝑪𝑮𝑻 𝑵𝒆𝒘𝒔: Regeneron Pharmaceuticals announced updated data for its investigational gene therapy, DB-OTO. In the phase 1/2 trial, 10 of 11 children with at least one post-treatment assessment showed notable improvements in hearing.

Read the full report here: https://www.cellgenetherapyreview.com/3972-News/617923-Regeneron-gene-therapy-restores-hearing-in-small-trial-of-children-with-genetic-hearing-loss/?utm_source=facebook&utm_medium=social

02/24/2025

bluebird bio has entered into a definitive agreement to be acquired by global investment firms Carlyle and SK Capital Partners, at a price of $3 per share.

More on the update here: https://www.cellgenetherapyreview.com/3972-News/617863-bluebird-sold-to-private-equity-firms-Carlyle-and-SK-Capital/?utm_source=facebook&utm_medium=social

02/19/2025

Solid Biosciences shares promising early data for Duchenne gene therapy

Read the news here - https://www.cellgenetherapyreview.com/3972-News/617785-Solid-Biosciences-shares-promising-early-data-for-Duchenne-gene-therapy/

&D

02/12/2025

As technological advances have transformed our capacity to probe biological parameters and mechanisms of health and disease, biomarkers have played a growing role in countless aspects of medicine.

Click here to read our latest article by Catherine Bladen PhD, and discover how biomarkers have become indispensable in the creation and optimization of cutting-edge treatments: https://www.cellgenetherapyreview.com/3975-Featured-Articles/617670-Charting-a-path-with-biomarker-discovery-tools/?utm_source=facebook&utm_medium=social

02/06/2025

China's Commerce Ministry has placed U.S.-based DNA sequencing and life sciences technologies company Illumina on its ‘unreliable entity’ list, in what appears to be retaliatory action following new U.S. tariffs on Chinese goods.

More about the change here: https://www.cellgenetherapyreview.com/3972-News/617569-China-adds-Illumina-to-government-watchlist/?utm_source=facebook&utm_medium=social

02/03/2025

Tenaya Therapeutics announced that the California Institute for Regenerative Medicine (CIRM), a state agency that funds regenerative medicine, stem cell and gene therapy research, has awarded the company an $8 million clinical grant.

Read the full article here: https://www.cellgenetherapyreview.com/3972-News/617527-Tenaya-wins-8M-grant-to-advance-cardio-gene-therapy-trials/?utm_source=facebook&utm_medium=social

01/06/2025

CGT top 10 storylines

As we head into a new year, it’s time to look back at 2024 and appreciate the tremendous progress made in cell and gene therapy

Read the article by Mark Flower here - https://www.cellgenetherapyreview.com/3975-Featured-Articles/617027-CGT-top-10-storylines/

Address

164 Townsend Street
San Francisco, CA
94107

Website

https://www.cellgenetherapyreview.com/

Alerts

Be the first to know and let us send you an email when Cell & Gene Therapy Review posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Media Company in San Francisco?

Cell & Gene Therapy Review

02/27/2025

02/24/2025

02/19/2025

02/12/2025

02/06/2025

02/03/2025

01/30/2025

01/28/2025

01/23/2025

01/17/2025

01/13/2025

01/06/2025

Address

Website

Alerts

Shortcuts

Share

Category